Sandler Capital Management Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$26.5M |
| 2 |
Vulcan Materials
VMC
|
+$25.8M |
| 3 |
HOLX
Hologic
HOLX
|
+$20.6M |
| 4 |
NVIDIA
NVDA
|
+$16.5M |
| 5 |
Visa
V
|
+$16.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CrowdStrike
CRWD
|
+$19.5M |
| 2 |
Hubbell
HUBB
|
+$17.6M |
| 3 |
Home Depot
HD
|
+$14.9M |
| 4 |
Palo Alto Networks
PANW
|
+$14M |
| 5 |
Zscaler
ZS
|
+$13.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 20.22% |
| 2 | Technology | 14.49% |
| 3 | Healthcare | 13.79% |
| 4 | Materials | 5.07% |
| 5 | Financials | 4.65% |
Similar funds
Sandler Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Sandler Capital Management held 113 positions worth $976M, up 36% from $717M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Sandler Capital Management deployed $257M of net new capital in Q4 2022, opening 31 new positions and adding to 29 existing holdings. Its largest new stake was Charles River Laboratories: 121,400 shares worth $26.5M.
By sector, the portfolio is most concentrated in Industrials at 20% of assets, down from 24% a quarter earlier, followed by Technology and Healthcare.
On the sell side, the largest reduction was Hubbell, an estimated $17.6M trimmed.
- Sandler Capital Management's largest Q4 2022 buy was Charles River Laboratories: 121,400 shares worth $26.5M.
- Sandler Capital Management added most to Visa in Q4 2022, an estimated $16.2M increase.
- Sandler Capital Management's biggest Q4 2022 reduction was Hubbell, cutting an estimated $17.6M.
- Sandler Capital Management fully exited CrowdStrike in Q4 2022, selling an estimated $19.5M.
- Sandler Capital Management's ten largest holdings make up 30% of its $976M portfolio in Q4 2022.
- Sandler Capital Management opened 31 new positions and closed 22 in Q4 2022.
- Sandler Capital Management's portfolio value rose 36% quarter-over-quarter to $976M.
Based on Sandler Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.